The Daily Pulse

Politics

White House withdraws Dr. Heidi Overton as FDA commissioner nominee

Reported by Kunal Bhatia (Senior Writer) · CBS News - Politics ·

Verified — Confirmed by a second source: Google News - USA Politics (search)

Confirmed by a second source: Google News - USA Politics (search)

Major
White House withdraws Dr. Heidi Overton as FDA commissioner nomineePhoto: Wikimedia Commons

The White House has dropped the nomination of Dr. Heidi Overton for Food and Drug Administration commissioner. A Senate health committee had scheduled a vote on her nomination for Wednesday, but the White House shared its decision to withdraw her Tuesday evening. President Trump nominated Overton over the summer. She is a physician and White House domestic policy staffer. Overton struggled to secure enough support among Senate Republicans. Lawmakers and administration allies had questioned her testimony about the abortion drug mifepristone and her work on pro-vape policies. Republican Senator Bill Cassidy of Louisiana had said he saw a possible pathway for her to advance, and the committee had not told the White House it lacked the votes. Before the decision, the White House had already talked to other potential candidates, including people who could serve in an acting capacity and skip Senate confirmation. The agency is currently led by acting Commissioner Kyle Diamantas. Two sources also indicated that Senator Roger Marshall of Kansas is making a play for the post after losing his reelection bid.

Context

The Food and Drug Administration regulates products that make up about twenty percent of United States consumer spending. Any permanent leader needs Senate confirmation before a narrow window closes when Democrats take control of the chamber in January. The agency has lacked a confirmed leader since Dr. Marty Makary left in May.

Read more at CBS News - Politics →